Suppr超能文献

病毒性视网膜炎的管理

Management of viral retinitis.

作者信息

Schulman J A, Peyman G A

机构信息

Department of Ophthalmology, Louisiana State University Medical Center, Shreveport.

出版信息

Ophthalmic Surg. 1988 Dec;19(12):876-84.

PMID:2852786
Abstract

Cytomegalovirus, herpes simplex, and herpes zoster are responsible for the majority of cases of viral retinitis. Herpes zoster also has been strongly incriminated as a causal agent in acute retinal necrosis. Effective chemotherapy exists for retinitis caused by herpes simplex and herpes zoster, along with acute retinal necrosis. Conventional antiviral therapy and immunomodulators are ineffective in the treatment of cytomegalovirus retinitis in patients with acquired immune deficiency disorder. Ganciclovir, a new antiviral agent, has significantly reduced visual morbidity in these patients. Recurrence of the infection is not uncommon while patients are on the drug or when the agent is discontinued, because ganciclovir is virostatic and does not stop viral replication in the retina. The inability to control this viral retinitis using presently available chemotherapy indicates a need to examine other therapeutic modalities.

摘要

巨细胞病毒、单纯疱疹病毒和带状疱疹病毒是大多数病毒性视网膜炎病例的病因。带状疱疹也被确认为急性视网膜坏死的致病因素。对于由单纯疱疹病毒、带状疱疹病毒引起的视网膜炎以及急性视网膜坏死,存在有效的化疗方法。传统的抗病毒疗法和免疫调节剂对获得性免疫缺陷症患者的巨细胞病毒性视网膜炎治疗无效。一种新型抗病毒药物更昔洛韦已显著降低了这些患者的视力损害。在患者用药期间或停药后,感染复发并不罕见,因为更昔洛韦是一种病毒抑制剂,无法阻止视网膜中的病毒复制。目前可用的化疗方法无法控制这种病毒性视网膜炎,这表明需要研究其他治疗方式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验